While many PED users have other risk factors for ASCVD, unfortunately because of their putative effects on thrombogenesis, high dose AAS may be all that's required for vascular occlusion.
To that end prophylactic ASA may be a reasonable means of lowering thrombogenic risk.
To that end prophylactic ASA may be a reasonable means of lowering thrombogenic risk.
Attachments
Last edited: